Skip to main content
Year archive

CAMBIUM BIO LIMITED — 2025 filings

All 52 regulatory filings released by CAMBIUM BIO LIMITED (CMB) in 2025, sourced directly from the official regulator.

52 Filings
2025 Period
2025 filings (52)
Filing Released Lang
Corrective Appendix 3Y Terrence Walts 4 pages 353.3KB
Director's Dealing
2025-10-26 English
Quarterly Activities/Appendix 4C Cash Flow Report 11 pages 402.1KB
Interim / Quarterly Report
2025-10-26 English
Change of Directors Interest Notice - EW 2 pages 230.2KB
Director's Dealing
2025-10-23 English
Change of Directors Interest Notice - TW 2 pages 229.8KB
Director's Dealing
2025-10-23 English
Amended Constitution 56 pages 568.9KB
Governance Information
2025-10-16 English
Cambium AGM CEO address 9 pages 1.3MB
AGM Information
2025-10-15 English
Results of Annual General Meeting 4 pages 107.9KB
Declaration of Voting Results & Voting Rights Announcements
2025-10-15 English
Application for quotation of securities - CMB 6 pages 18.4KB
Share Issue/Capital Change
2025-10-15 English
Notification regarding unquoted securities - CMB 5 pages 16.7KB
Share Issue/Capital Change
2025-10-15 English
Cleansing notice 1 page 143.3KB
Capital/Financing Update
2025-10-15 English
Cambium Bio Signs Manufacturing MOU with Locus Cell 4 pages 147.9KB
Capital/Financing Update
2025-09-29 English
Notice of Annual General Meeting and Proxy form 26 pages 626.4KB
AGM Information
2025-09-14 English
Proposed issue of securities - CMB 5 pages 18.9KB
Capital/Financing Update
2025-09-14 English
Cambium Bio Signs Strategic MoU with Benta SAS 4 pages 162.5KB
Capital/Financing Update
2025-09-04 English
Cambium Bio Signs US$2.0M plus Licensing Deal 4 pages 160.8KB
Capital/Financing Update
2025-09-01 English
Application for quotation of securities - CMB 6 pages 18.4KB
Share Issue/Capital Change
2025-08-28 English
Cleansing notice 1 page 123.9KB
Capital/Financing Update
2025-08-28 English
FY25 Appendix 4E and Annual Report 63 pages 3.3MB
Annual Report
2025-08-28 English
FY25 Appendix 4G and Corporate Governance Statement 24 pages 716.3KB
Regulatory Filings
2025-08-28 English
Placement Participant Update 2 pages 134.3KB
Capital/Financing Update
2025-08-26 English
Update - Proposed issue of securities - CMB 5 pages 18.3KB
Capital/Financing Update
2025-08-26 English
Quarterly Activities/Appendix 4C Cash Flow Report 9 pages 357.6KB
Interim / Quarterly Report
2025-07-30 English
Cambium Bio Raises A$2.12 million 3 pages 128.6KB
Capital/Financing Update
2025-07-29 English
Proposed issue of securities - CMB 5 pages 18.4KB
Capital/Financing Update
2025-07-29 English
Cambium Bio Clears FDA Regulatory Hurdles 2 pages 115.3KB
Regulatory Filings
2025-07-10 English
Cambium Bio Receives Ethics Approvals 3 pages 149.5KB
Regulatory Filings
2025-06-29 English
Change of Address 1 page 88.6KB
Regulatory Filings
2025-05-22 English
Final Director's Interest Notice - Barry Sechos 2 pages 193.2KB
Director's Dealing
2025-05-21 English
Initial Director's Interest Notice - Denese Marks 2 pages 196.7KB
Director's Dealing
2025-05-21 English
Board and Company Secretary Changes 3 pages 157.3KB
Board/Management Information
2025-05-20 English
Quarterly Activities/Appendix 4C Cash Flow Report 8 pages 336.5KB
Interim / Quarterly Report
2025-04-27 English
Change of registry address 1 page 69.9KB
Regulatory Filings
2025-04-13 English
Notice of ceasing to be a substantial holder 2 pages 270.5KB
Major Shareholding Notification
2025-04-10 English
Cambium Bio - Release of Shares from Escrow 1 page
Share Issue/Capital Change
2025-03-20 English
FDA Approves Cambium Bio's Potency Assay Strategy for Elate 2 pages 84.3KB
Regulatory Filings
2025-03-17 English
Notice of change of interests of substantial holder-CMB 3 pages 327.7KB
Major Shareholding Notification
2025-03-17 English
Application for quotation of securities - CMB 6 pages 18.1KB
Share Issue/Capital Change
2025-03-11 English
Notification regarding unquoted securities - CMB 5 pages 16.7KB
Share Issue/Capital Change
2025-03-11 English
Change of Directors Interest Notice 10 pages 471.3KB
Director's Dealing
2025-03-11 English
Mr Chiu - Director Appointment and Appedix 3X 4 pages 266.5KB
Board/Management Information
2025-03-06 English
Results of General Meeting 4 pages 155.4KB
Declaration of Voting Results & Voting Rights Announcements
2025-03-03 English
Response to queries re Appendices 3X and 3Z 1 page
Regulatory Filings
2025-03-02 English
Update - Proposed issue of securities - CMB 5 pages 18.1KB
Capital/Financing Update
2025-02-27 English
Half Year Report and Accounts 20 pages 2.1MB
Interim / Quarterly Report
2025-02-26 English
FDA Approves Elate Ocular Phase 3 Clinical Trial Protocol 3 pages 109.8KB
Regulatory Filings
2025-02-24 English
Initial and Final Director Interest Notices-Chandra Bala 6 pages 341.5KB
Director's Dealing
2025-02-16 English
Final Director Interest Notice-Graham Vesey 2 pages 204.9KB
Director's Dealing
2025-02-16 English
Application for quotation of securities - CMB 6 pages 18.4KB
Share Issue/Capital Change
2025-02-12 English
Placement Shares Cleansing Notice 1 page 101.2KB
Share Issue/Capital Change
2025-02-12 English
Quarterly Activities/Appendix 4C Cash Flow Report 9 pages 387.6KB
Interim / Quarterly Report
2025-01-30 English
Notice of General Meeting/Proxy Form 71 pages 1.8MB
Proxy Solicitation & Information Statement
2025-01-29 English
Change in substantial holding 2 pages 3.4MB
Regulatory Filings
2025-01-06 English